Science Publishing Is Urgently In Need Of Major Reform

VOLUME 7, No:17 The Scientist September 6, 1993 Opinion Science Publishing Is Urgently In Need Of Major Reform AUTHOR: RUSTUM ROY, pp.11 The function of science publishing today is to get information about new findings in science to at least three different communities: Group A, the specialists working in the same field as that in which the findings were made (numbering anywhere from 10 to 1,000 scientists); Group B, the general community of scientists and engineers who, a

Written byRustum Roy
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The function of science publishing today is to get information about new findings in science to at least three different communities:

The classic media for science publishing--journals put out by societies and other discipline-oriented organizations--were designed only for Group A, while the media serving Group B are the short news articles in society house organs, such as Chemical Engineering News, Physics Today, and MRS Bulletin, and in such multidisciplinary publications as Science and Nature. Group C is served (very poorly, in my opinion) by the general media--including newspapers and magazines such as the New York Times, Omni, and Discover--which tend to overamplify and inappropriately dramatize the "breakthroughs" they consider newsworthy. Since maximum publicity--not accuracy--today serves both the scientist and the journalist, these and other such publications, in my opinion, tend increasingly to fall for exaggeration and hype. Meanwhile, such publications as New Scientist and The Scientist seek to bridge with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies